METHODS: Ninety older adults (50 LLD and 40 controls (HC)) participated in the study. Blood was collected and exosomes were isolated using size-exclusion chromatography. DNA was extracted and EX-mtDNA levels and deletion were assessed using qPCR. Plasma TNFRI and TNFRII levels were quantified by multiplex immunoassay. Correlation analysis explored relationships between EX-mtDNA, clinical outcomes, and inflammatory markers.
RESULTS: Although no differences were observed in EX-mtDNA levels between groups, elevated levels correlated with poorer cognitive performance (r = -0.328, p = 0.002) and increased TNFRII levels (r = 0.367, p = 0.004). LLD exhibited higher deletion rates (F(83,1) = 4.402, p = 0.039), with a trend remaining after adjusting for covariates (p = 0.084). Deletion correlated with poorer cognitive performance (r = -0.335, p = 0.002). No other associations were found.
CONCLUSIONS: Cross-sectional study with a small number of participants from a specialized geriatric psychiatry treatment center.
CONCLUSIONS: Our findings suggest that EX-mtDNA holds promise as an indicator of cognitive outcomes in LLD. Additional research is needed to further comprehend the role of EX-mtDNA levels/integrity in LLD, paving the way for its clinical application in the future.
方法:90名老年人(50名LLD和40名对照(HC))参与了这项研究。收集血液并使用尺寸排阻色谱法分离外泌体。提取DNA并使用qPCR评估EX-mtDNA水平和缺失。通过多重免疫测定定量血浆TNFRI和TNFRII水平。相关分析探讨了EX-mtDNA,临床结果,和炎症标志物。
结果:尽管没有观察到组间EX-mtDNA水平的差异,水平升高与认知能力较差(r=-0.328,p=0.002)和TNFRII水平升高(r=0.367,p=0.004)相关.LLD表现出更高的缺失率(F(83,1)=4.402,p=0.039),在调整协变量后保持趋势(p=0.084)。缺失与较差的认知表现相关(r=-0.335,p=0.002)。没有发现其他关联。
结论:对来自专门老年精神病学治疗中心的少数参与者进行的横断面研究。
结论:我们的研究结果表明,EX-mtDNA有望作为LLD认知结果的指标。需要更多的研究来进一步理解EX-mtDNA水平/完整性在LLD中的作用,为其未来的临床应用铺平了道路。